Propionibacterium acnes

Open Access

Clinical Therapeutics
Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris
Sarecycline is the first narrow-spectrum tetracycline-class antibiotic being developed for acne treatment. In addition to exhibiting activity against important skin/soft tissue pathogens, sarecycline exhibits targeted antibacterial activity against clinical isolates of Cutibacterium acnes.

George Zhanel, Ian Critchley, Lynn-Yao Lin, Nancy Alvandi
Susceptibility
In Vitro Activities of Pexiganan and 10 Comparator Antimicrobials against 502 Anaerobic Isolates Recovered from Skin and Skin Structure Infections
Ellie J. C. Goldstein, Diane M. Citron, Kerin L. Tyrrell, Eliza S. Leoncio
Experimental Therapeutics
Activity of Electrical Current in Experimental Propionibacterium acnes Foreign-Body Osteomyelitis
Suzannah M. Schmidt-Malan, Cassandra L. Brinkman, Kerryl E. Greenwood-Quaintance, Melissa J. Karau, Jayawant N. Mandrekar, Robin Patel
Experimental Therapeutics
Activity of an Antimicrobial Hydrocephalus Shunt Catheter against Propionibacterium acnes
Roger Bayston, Litza Vera, Waheed Ashraf
Susceptibility
A Peptide with a ProGln C Terminus in the Human Saliva Peptidome Exerts Bactericidal Activity against Propionibacterium acnes
Chun-Ming Huang, Justin W. Torpey, Yu-Tseung Liu, Yun-Ru Chen, Katherine E. Williams, Elizabeth A. Komives, Richard L. Gallo
Mechanisms of Action: Physiological Effects
Activity of the Novel Macrolide BAL19403 against Ribosomes from Erythromycin-Resistant Propionibacterium acnes
Jürg Dreier, Eva Amantea, Laurenz Kellenberger, Malcolm G. P. Page
Susceptibility
In Vitro Activities of Daptomycin, Vancomycin, and Penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes
Kerin L. Tyrrell, Diane M. Citron, Yumi A. Warren, Helen T. Fernandez, C. Vreni Merriam, Ellie J. C. Goldstein
Susceptibility
Comparative In Vitro Activities of Retapamulin (SB-275833) against 141 Clinical Isolates of Propionibacterium spp., Including 117 P. acnes Isolates
Ellie J. C. Goldstein, Diane M. Citron, C. Vreni Merriam, Yumi A. Warren, Kerin L. Tyrrell, Helen T. Fernandez
LETTERS TO THE EDITOR
Susceptibilities of Propionibacterium acnesOphthalmic Isolates to Moxifloxacin
Pilu Dali, Edmund R. Giugliano, Ernestine M. Vellozzi, Miriam A. Smith

Main menu

User menu

Search

Propionibacterium acnes